The flavor is pretty good, and the packets are so convenient
Protocol modifications: Start lower doses (BPC-157 200mcg vs 500mcg, GHK-Cu 1mg vs 3mg) with slower titration, simplify regimens (once daily vs multiple doses), prioritize evidence-based options (Cerebrolysin for glaucoma over speculative peptides), involve family members in administration and monitoring, focus on most impactful intervention if resources limited
The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo
A better understanding of these physiological abnormalities could lead to the discovery of novel pathways for treatments of potentially many neurodevelopmental disorders and other neurological disorders involving abnormalities in these metabolic pathways
Dosage can be gradually increased as tolerated to achieve the desired effects
Extreme Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act